JBT Marel reports FY2025 revenue $3.8B, adj. EBITDA $600M; guides FY2026 growth 5-7%

JBT MAREL Corp

2025-FY EPS reported -$0.98 revenue$3,798,200,000

FY2025 revenue $3.8B, record Q4 revenue exceeding $1.0B; adjusted EBITDA $600M (15.8% margin).
Adjusted EPS $6.41; free cash flow $250M; net debt/EBITDA 2.9x (de-levered ~1.1x since deal close).
FY2026 guidance: revenue $3,990-4,065M, adj. EBITDA margin 17.0-17.5%, adj. EPS $8.00-8.50.
Realized $43M synergy savings in 2025, $85M annualized run rate exiting 2025; expect $60M in 2026.
Segments realigned: Protein Solutions ($1.72B rev, 20.1% margin); Prepared Food & Beverage ($2.08B rev, 17.2% margin).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.